Investigational Therapy

jCyte, a clinical-stage biotech company, has entered into a licensing agreement with Santen Pharmaceuticals to develop and commercialize its jCell therapy outside the United States.

WASHINGTON — An investigational vaccine failed to prevent chronic hepatitis C virus infection in a cohort of at-risk adults, according to results of a clinical trial presented at IDWeek.